Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Economy
Global Metrics

PDL BioPharma Gross Profit 2006-2020 | PDLI

PDL BioPharma gross profit from 2006 to 2020. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
PDL BioPharma Annual Gross Profit
(Millions of US $)
2020 $
2019 $1
2018 $150
2017 $290
2016 $240
2015 $590
2014 $581
2013 $456
2012 $381
2011 $362
2010 $345
2009 $318
2008 $294
2007 $225
2006 $187
2005 $158
PDL BioPharma Quarterly Gross Profit
(Millions of US $)
2020-12-31
2020-06-30 $3
2020-03-31 $3
2019-12-31 $-33
2019-09-30 $29
2019-06-30 $3
2019-03-31 $3
2018-12-31 $34
2018-09-30 $56
2018-06-30 $32
2018-03-31 $28
2017-12-31 $50
2017-09-30 $57
2017-06-30 $139
2017-03-31 $43
2016-12-31 $66
2016-09-30 $54
2016-06-30 $21
2016-03-31 $103
2015-12-31 $178
2015-09-30 $125
2015-06-30 $138
2015-03-31 $150
2014-12-31 $117
2014-09-30 $165
2014-06-30 $163
2014-03-31 $137
2013-12-31 $116
2013-09-30 $100
2013-06-30 $149
2013-03-31 $92
2012-12-31 $92
2012-09-30 $85
2012-06-30 $126
2012-03-31 $77
2011-12-31 $73
2011-09-30 $84
2011-06-30 $122
2011-03-31 $83
2010-12-31 $76
2010-09-30 $86
2010-06-30 $120
2010-03-31 $62
2009-12-31 $58
2009-09-30 $71
2009-06-30 $126
2009-03-31 $63
2008-12-31 $69
2008-09-30 $69
2008-06-30 $107
2008-03-31 $50
2007-12-31 $50
2007-09-30 $61
2007-06-30 $89
2007-03-31 $59
2006-12-31 $60
2006-09-30 $94
2006-06-30 $83
2006-03-31 $68
2005-12-31 $67
2005-09-30 $55
2005-06-30 $61
2005-03-31 $38
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.000B $0.055B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Moderna (MRNA) United States $155.195B 309.21
Bristol Myers Squibb (BMY) United States $154.015B 10.25
Amgen (AMGN) United States $140.237B 15.01
CSL (CSLLY) Australia $99.509B 0.00
Gilead Sciences (GILD) United States $87.579B 8.46
BioNTech SE (BNTX) Germany $84.970B 61.61
Illumina (ILMN) United States $72.769B 104.93
Regeneron Pharmaceuticals (REGN) United States $62.489B 17.89
Vertex Pharmaceuticals (VRTX) United States $51.899B 20.17
Biogen (BIIB) United States $50.373B 13.83
BeiGene (BGNE) Cayman Islands $31.544B 0.00
Genmab (GNMSF) Denmark $30.486B 6.62
Genmab (GMAB) Denmark $30.385B 35.59
Seagen (SGEN) United States $28.780B 48.53
Horizon Therapeutics Public (HZNP) Ireland $22.423B 28.67
Alnylam Pharmaceuticals (ALNY) United States $21.018B 0.00
Bio-Rad Laboratories (BIO.B) United States $20.768B 44.27
Bio-Techne Corp (TECH) United States $18.717B 98.42
Exact Sciences (EXAS) United States $17.919B 0.00
Incyte (INCY) United States $17.143B 40.81
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.250B 0.00
ARGENX SE-ADR (ARGX) Netherlands $16.024B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.237B 102.17
Zai Lab (ZLAB) China $14.001B 0.00
Novavax (NVAX) United States $13.972B 0.00
Repligen (RGEN) United States $13.675B 104.21
QIAGEN (QGEN) Netherlands $11.967B 20.27
Guardant Health (GH) United States $11.173B 0.00
CureVac (CVAC) Germany $10.194B 0.00
Intellia Therapeutics (NTLA) United States $9.459B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $9.252B 23.76
Mirati Therapeutics (MRTX) United States $8.399B 0.00
Fate Therapeutics (FATE) United States $7.828B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $7.729B 0.00
Acceleron Pharma (XLRN) United States $7.467B 0.00
Ascendis Pharma (ASND) Denmark $6.594B 0.00
Legend Biotech (LEGN) United States $6.484B 0.00
Denali Therapeutics (DNLI) United States $6.197B 222.30
I-Mab (IMAB) China $6.014B 0.00
Twist Bioscience (TWST) United States $5.819B 0.00
Beam Therapeutics (BEAM) United States $5.777B 0.00
Halozyme Therapeutics (HALO) United States $5.738B 31.48
Ultragenyx Pharmaceutical (RARE) United States $5.653B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $5.550B 19.89
Sarepta Therapeutics (SRPT) United States $5.508B 0.00
NeoGenomics (NEO) United States $5.447B 923.80
Exelixis (EXEL) United States $5.318B 84.85
Apellis Pharmaceuticals (APLS) United States $5.123B 0.00
Adaptive Biotechnologies (ADPT) United States $5.048B 0.00
Blueprint Medicines (BPMC) United States $5.037B 14.21
Arvinas (ARVN) United States $4.918B 0.00
Reata Pharmaceuticals (RETA) United States $4.659B 0.00
Vir Biotechnology (VIR) United States $4.538B 0.00
Alkermes (ALKS) Ireland $4.495B 132.67
AbCellera Biologics (ABCL) $4.267B 0.00
SpringWorks Therapeutics (SWTX) United States $4.201B 0.00
Certara (CERT) United States $4.025B 0.00
Galapagos (GLPG) Belgium $3.997B 0.00
Arena Pharmaceuticals (ARNA) United States $3.668B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.465B 0.00
Emergent Biosolutions (EBS) United States $3.404B 8.21
Berkeley Lights (BLI) United States $2.984B 0.00
Editas Medicine (EDIT) United States $2.856B 0.00
Dicerna Pharmaceuticals (DRNA) United States $2.838B 0.00
Intra-Cellular Therapies (ITCI) United States $2.806B 0.00
Myriad Genetics (MYGN) United States $2.715B 0.00
Kymera Therapeutics (KYMR) United States $2.702B 0.00
Heska (HSKA) United States $2.651B 518.90
BAVARIAN NORDIC (BVNRY) Denmark $2.623B 0.00
Insmed (INSM) United States $2.488B 0.00
Amicus Therapeutics (FOLD) United States $2.482B 0.00
ALX Oncology Holdings (ALXO) United States $2.475B 0.00
Sorrento Therapeutics (SRNE) United States $2.437B 0.00
Vericel (VCEL) United States $2.398B 646.50
Prothena (PRTA) Ireland $2.390B 0.00
Atea Pharmaceuticals (AVIR) United States $2.303B 0.00
Protagonist Therapeutics (PTGX) United States $2.165B 0.00
Revance Therapeutics (RVNC) United States $2.157B 0.00
Arcus Biosciences (RCUS) United States $2.131B 0.00
Instil Bio (TIL) United States $2.102B 0.00
Celldex Therapeutics (CLDX) United States $2.086B 0.00
Cytokinetics (CYTK) United States $2.068B 0.00
Alector (ALEC) United States $2.057B 0.00
C4 Therapeutics (CCCC) United States $1.984B 0.00
Morphic Holding (MORF) United States $1.941B 0.00
Myovant Sciences (MYOV) United Kingdom $1.904B 0.00
Seer (SEER) $1.902B 0.00
Ligand Pharmaceuticals (LGND) United States $1.849B 27.08
Inovio Pharmaceuticals (INO) United States $1.803B 0.00
MorphoSys AG (MOR) Germany $1.801B 0.00
Castle Biosciences (CSTL) United States $1.763B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.711B 0.00
Amarin (AMRN) Ireland $1.698B 0.00
Bluebird Bio (BLUE) United States $1.694B 0.00
Global Blood Therapeutics (GBT) United States $1.674B 0.00
Bionano Genomics (BNGO) United States $1.651B 0.00
PHARMA MAR SA (PHMMF) Spain $1.585B 0.00
Avid Bioservices (CDMO) United States $1.578B 645.50
ADC Therapeutics SA (ADCT) Switzerland $1.554B 0.00
NGM Biopharmaceuticals (NGM) United States $1.552B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.546B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $1.533B 0.00
Nurix Therapeutics (NRIX) United States $1.493B 0.00
Y-mAbs Therapeutics (YMAB) United States $1.491B 0.00
Zymeworks (ZYME) Canada $1.475B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $1.461B 0.00
MiMedx (MDXG) United States $1.405B 0.00
Ocugen (OCGN) United States $1.398B 0.00
Codexis (CDXS) United States $1.394B 0.00
Sangamo Therapeutics (SGMO) United States $1.378B 0.00
PureTech Health (PRTC) United States $1.366B 0.00
REGENXBIO (RGNX) United States $1.362B 0.00
UniQure (QURE) Netherlands $1.353B 4.60
BioAtla (BCAB) United States $1.347B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.341B 0.00
Zealand Pharma (ZEAL) Denmark $1.328B 0.00
Genetron Holdings (GTH) China $1.256B 0.00
Repare Therapeutics (RPTX) Canada $1.240B 0.00
Agenus (AGEN) United States $1.212B 0.00
Precigen (PGEN) United States $1.129B 0.00
Dynavax Technologies (DVAX) United States $1.116B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.109B 0.00
Nkarta (NKTX) United States $1.091B 0.00
Scholar Rock Holding (SRRK) United States $1.042B 0.00
Zealand Pharma (ZLDPF) Denmark $1.035B 0.00
Inhibrx (INBX) United States $1.033B 0.00
Coherus BioSciences (CHRS) United States $1.001B 0.00
MannKind (MNKD) United States $0.994B 0.00
Northwest Biotherapeutics (NWBO) United States $0.984B 0.00
Mesoblast (MESO) Australia $0.961B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.941B 29.17
KaloBios Pharmaceuticals (HGEN) United States $0.938B 0.00
Travere Therapeutics (TVTX) United States $0.860B 0.00
Shattuck Labs (STTK) United States $0.842B 0.00
Prometheus Biosciences (RXDX) United States $0.841B 0.00
Sutro Biopharma (STRO) United States $0.825B 0.00
Keros Therapeutics (KROS) United States $0.810B 0.00
IDEAYA Biosciences (IDYA) United States $0.807B 0.00
VBI Vaccines (VBIV) United States $0.794B 0.00
RAPT THERAPTICS (RAPT) United States $0.778B 0.00
Kadmon Holdings (KDMN) United States $0.777B 0.00
Pliant Therapeutics (PLRX) United States $0.775B 0.00
Mersana Therapeutics (MRSN) United States $0.759B 0.00
Pharming Group (PHAR) Netherlands $0.730B 0.00
Adagene (ADAG) China $0.728B 0.00
Pharming Group (PHGUF) Netherlands $0.720B 23.00
Avidity Biosciences (RNA) United States $0.716B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.714B 0.00
G1 THERAPEUTICS (GTHX) United States $0.708B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.706B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.695B 0.00
Merus (MRUS) Netherlands $0.694B 0.00
SESEN BIO, INC (SESN) United States $0.691B 0.00
Affimed (AFMD) Germany $0.677B 0.00
Epizyme (EPZM) United States $0.669B 0.00
AnaptysBio (ANAB) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.642B 6.47
Curis (CRIS) United States $0.640B 0.00
Seres Therapeutics (MCRB) United States $0.638B 0.00
Cellectis S.A (CLLS) France $0.619B 0.00
MeiraGTx Holdings (MGTX) United States $0.617B 0.00
Akoya Biosciences (AKYA) United States $0.615B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.603B 0.00
ChromaDex (CDXC) United States $0.593B 0.00
Anika Therapeutics (ANIK) United States $0.588B 0.00
Cara Therapeutics (CARA) United States $0.584B 50.74
Precision BioSciences (DTIL) United States $0.563B 0.00
Brooklyn ImmunoTherapeutics (BTX) United States $0.560B 0.00
Intercept Pharmaceuticals (ICPT) United States $0.552B 0.00
ALBIREO PHARMA (ALBO) United States $0.547B 0.00
DBV Technologies S.A (DBVT) France $0.547B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.541B 0.00
VistaGen Therapeutics (VTGN) United States $0.530B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.521B 9.50
Verastem (VSTM) United States $0.521B 0.00
AC Immune SA (ACIU) Switzerland $0.518B 0.00
Vaccitech (VACC) United Kingdom $0.517B 0.00
Clene (CLNN) United States $0.508B 0.00
Clovis Oncology (CLVS) United States $0.508B 0.00
Inventiva S.A (IVA) France $0.507B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.494B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.494B 0.00
XBiotech (XBIT) United States $0.484B 0.00
Cybin (CLXPF) Canada $0.456B 0.00
Compugen (CGEN) Israel $0.451B 0.00
Bolt Biotherapeutics (BOLT) United States $0.426B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.423B 0.00
ANI Pharmaceuticals (ANIP) United States $0.421B 11.61
Selecta Biosciences (SELB) United States $0.419B 0.00
Kindred Biosciences (KIN) United States $0.419B 0.00
Oncobiologics (OTLK) United States $0.418B 0.00
Athenex (ATNX) United States $0.415B 0.00
Spero Therapeutics (SPRO) United States $0.412B 0.00
Forte Biosciences (FBRX) United States $0.405B 0.00
Starpharma Holdings (SPHRY) Australia $0.401B 0.00
Codiak BioSciences (CDAK) United States $0.393B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.391B 0.00
Geron (GERN) United States $0.389B 0.00
BioDelivery Sciences (BDSI) United States $0.384B 15.60
BeyondSpring (BYSI) United States $0.377B 0.00
CytomX Therapeutics (CTMX) United States $0.373B 0.00
Amryt Pharma (AMYT) United Kingdom $0.370B 0.00
XOMA (XOMA) United States $0.367B 171.32
Cel-Sci (CVM) United States $0.355B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.345B 0.00
SQZ Biotechnologies (SQZ) United States $0.338B 0.00
AquaBounty Technologies (AQB) United States $0.337B 0.00
Athersys (ATHX) United States $0.335B 0.00
Theratechnologies (THTX) Canada $0.332B 0.00
Gritstone Bio (GRTS) United States $0.330B 0.00
UROGEN PHARMA (URGN) United States $0.328B 0.00
Cue Biopharma (CUE) United States $0.328B 0.00
Angion Biomedica (ANGN) United States $0.325B 0.00
Opthea (OPT) Australia $0.316B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.307B 0.00
Fortress Biotech (FBIO) United States $0.306B 0.00
Clearside Biomedical (CLSD) United States $0.295B 0.00
Puma Biotechnology (PBYI) United States $0.295B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.291B 0.00
Neoleukin Therapeutics (NLTX) United States $0.288B 0.00
Frequency Therapeutics (FREQ) United States $0.284B 0.00
Syros Pharmaceuticals (SYRS) United States $0.283B 0.00
WAVE Life Sciences (WVE) Singapore $0.280B 0.00
Prima BioMed (IMMP) Australia $0.273B 0.00
IBio (IBIO) United States $0.268B 0.00
Innate Pharma S.A (IPHA) France $0.266B 0.00
Arbutus Biopharma (ABUS) United States $0.265B 0.00
Talis Biomedical (TLIS) United States $0.260B 0.00
Cerecor (CERC) United States $0.258B 0.00
Kamada (KMDA) Israel $0.257B 17.51
OVID THERAPEUTC (OVID) United States $0.251B 2.47
Paratek Pharmaceuticals (PRTK) United States $0.251B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.246B 0.00
Kaleido Biosciences (KLDO) $0.241B 0.00
Cogent Biosciences (COGT) United States $0.240B 0.00
Fulcrum Therapeutics (FULC) United States $0.238B 0.00
Chiasma (CHMA) United States $0.234B 0.00
INmune Bio (INMB) United States $0.233B 0.00
Adicet Bio (ACET) United States $0.231B 0.00
Adverum Biotechnologies (ADVM) United States $0.231B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.230B 0.00
Bellus Health (BLU) Canada $0.230B 0.00
CorMedix Inc (CRMD) United States $0.225B 0.00
Trevena (TRVN) United States $0.224B 0.00
Kala Pharmaceuticals (KALA) United States $0.223B 0.00
OSMOTICA PHARM (OSMT) United States $0.222B 0.00
Checkpoint Therapeutics (CKPT) United States $0.204B 0.00
ADMA Biologics Inc (ADMA) United States $0.203B 0.00
NextCure (NXTC) United States $0.197B 0.00
TELA Bio (TELA) United States $0.197B 0.00
HOOKIPA Pharma (HOOK) United States $0.194B 0.00
Cardiff Oncology (CRDF) United States $0.193B 0.00
Beyond Air (XAIR) United States $0.183B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.179B 0.00
GENFIT S.A (GNFT) France $0.179B 0.00
Biofrontera AG (BFRA) Germany $0.178B 0.00
VolitionRX (VNRX) United States $0.175B 0.00
Aptinyx (APTX) United States $0.172B 0.00
Nicox SA (NICXF) France $0.171B 0.00
POXEL SA FRANCE (PXXLF) France $0.170B 0.00
Erytech Pharma SA (ERYP) France $0.168B 0.00
Seelos Therapeutics (SEEL) United States $0.164B 0.00
Strongbridge Biopharma (SBBP) United States $0.160B 0.00
PHASEBIO PHARMA (PHAS) United States $0.160B 0.00
Enzo Biochem (ENZ) United States $0.159B 47.00
VTv Therapeutics (VTVT) United States $0.158B 0.00
Applied Genetic Technologies (AGTC) United States $0.155B 0.00
Synlogic (SYBX) United States $0.152B 0.00
ObsEva SA (OBSV) Switzerland $0.144B 0.00
Eton Pharmaceuticals (ETON) United States $0.142B 0.00
X4 Pharmaceuticals (XFOR) United States $0.140B 0.00
LogicBio Therapeutics (LOGC) United States $0.137B 0.00
Purple Biotech (PPBT) Israel $0.137B 0.00
Galena Biopharma (SLS) United States $0.137B 0.00
Exicure (XCUR) United States $0.134B 0.00
Cyclerion Therapeutics (CYCN) United States $0.134B 0.00
Catalyst Biosciences (CBIO) United States $0.127B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.127B 0.00
Entera Bio (ENTX) Israel $0.125B 0.00
Abeona Therapeutics (ABEO) United States $0.125B 0.00
Voyager Therapeutics (VYGR) United States $0.124B 3.19
Orgenesis (ORGS) United States $0.123B 250.50
Viridian Therapeutics (VRDN) United States $0.122B 0.00
Liquidia Technologies (LQDA) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.118B 0.00
Novogen (KZIA) Australia $0.115B 0.00
Longeveron (LGVN) United States $0.108B 0.00
Eyenovia (EYEN) United States $0.108B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.108B 0.00
Cocrystal Pharma (COCP) United States $0.107B 0.00
F-star Therapeutics (FSTX) United Kingdom $0.105B 0.00
Pluristem Therapeutics (PSTI) Israel $0.104B 0.00
Yumanity Therapeutics (YMTX) United States $0.102B 0.00
Vascular Biogenics (VBLT) Israel $0.101B 0.00
Aytu BioPharma (AYTU) United States $0.098B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.096B 0.00
Celsion (CLSN) United States $0.093B 0.00
Dyadic (DYAI) United States $0.092B 0.00
Leap Therapeutics (LPTX) United States $0.091B 0.00
Liminal BioSciences (LMNL) Canada $0.088B 0.00
ARAVIVE, INC (ARAV) United States $0.088B 0.00
AEterna Zentaris (AEZS) United States $0.086B 0.00
Cidara Therapeutics (CDTX) United States $0.083B 0.00
Evofem Biosciences (EVFM) United States $0.082B 0.00
Zosano Pharma (ZSAN) United States $0.081B 0.00
Aptevo Therapeutics (APVO) United States $0.080B 0.00
Stealth BioTherapeutics (MITO) Cayman Islands $0.079B 0.00
Vyant Bio (VYNT) United States $0.078B 0.00
Adocia (ADOCY) France $0.077B 0.00
AIkido Pharma (AIKI) United States $0.075B 0.00
Evogene (EVGN) Israel $0.075B 0.00
Emmaus Life Sciences (EMMA) United States $0.074B 0.00
ATyr Pharma (LIFE) United States $0.073B 0.00
Protalix BioTherapeutics (PLX) Israel $0.072B 0.00
Vaccinex (VCNX) United States $0.070B 0.00
Organovo Holdings (ONVO) United States $0.066B 0.00
Celyad SA (CYAD) Belgium $0.066B 0.00
Lumos Pharma (LUMO) United States $0.064B 0.00
Edesa Biotech (EDSA) Canada $0.063B 0.00
Advaxis (ADXS) United States $0.063B 0.00
DiaMedica Therapeutics (DMAC) United States $0.062B 0.00
Alimera Sciences (ALIM) United States $0.059B 0.00
BioCardia (BCDA) United States $0.059B 0.00
Idera Pharmaceuticals (IDRA) United States $0.056B 0.00
Cytocom (CBLI) United States $0.055B 0.00
Windtree Therapeutics (WINT) United States $0.053B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
TRACON Pharmaceuticals (TCON) United States $0.053B 0.00
Cyclo Therapeutics (CYTH) United States $0.053B 0.00
ARIDIS PHARMACT (ARDS) United States $0.050B 0.00
AnPac Bio-Medical Science (ANPC) China $0.049B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.046B 0.00
Invo BioScience (INVO) United States $0.046B 0.00
Pulmatrix (PULM) United States $0.046B 0.00
Enveric Biosciences (ENVB) United States $0.041B 0.00
Happiness Biotech Group (HAPP) China $0.041B 0.00
Soligenix (SNGX) United States $0.039B 0.00
Timber Pharmaceuticals (TMBR) United States $0.037B 0.00
Acorda Therapeutics (ACOR) United States $0.037B 0.89
Lexaria Bioscience (LEXX) Canada $0.033B 0.00
Prana Biotechnology (ATHE) Australia $0.031B 0.00
Vallon Pharmaceuticals (VLON) United States $0.031B 0.00
ThermoGenesis Holdings (THMO) United States $0.029B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.028B 0.00
Benitec Biopharma (BNTC) United States $0.028B 0.00
IMMURON (IMRN) Australia $0.028B 0.00
GeoVax Labs (GOVX) United States $0.027B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.023B 0.00
ZIVO Bioscience (ZIVO) United States $0.018B 0.00
Palisade Bio (PALI) United States $0.008B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.000B 0.00
ImmunityBio (IBRX) United States $0.000B 0.00
Immatics (IMTX) Germany $0.000B 0.00